Ginwa Enterprise (Group) Inc. (600080.SS)

CNY 7.81

(0.51%)

Total Debt Summary of Ginwa Enterprise (Group) Inc.

  • Ginwa Enterprise (Group) Inc.'s latest annual total debt in 2023 was 10.77 Million CNY , down -31.99% from previous year.
  • Ginwa Enterprise (Group) Inc.'s latest quarterly total debt in 2024 Q2 was 79.65 Million CNY , up 145.41% from previous quarter.
  • Ginwa Enterprise (Group) Inc. reported annual total debt of 15.84 Million CNY in 2022, down 0.0% from previous year.
  • Ginwa Enterprise (Group) Inc. reported annual total debt of - CNY in 2021, down -100.0% from previous year.
  • Ginwa Enterprise (Group) Inc. reported quarterly total debt of 79.65 Million CNY for 2024 Q2, up 145.41% from previous quarter.
  • Ginwa Enterprise (Group) Inc. reported quarterly total debt of 42.62 Million CNY for 2024 Q3, down -34.18% from previous quarter.

Annual Total Debt Chart of Ginwa Enterprise (Group) Inc. (2023 - 1994)

Historical Annual Total Debt of Ginwa Enterprise (Group) Inc. (2023 - 1994)

Year Total Debt Total Debt Growth
2023 10.77 Million CNY -31.99%
2022 15.84 Million CNY 0.0%
2021 - CNY -100.0%
2020 50.09 Million CNY 0.2%
2019 50 Million CNY 0.0%
2018 50 Million CNY -66.67%
2017 150 Million CNY 0.0%
2016 150 Million CNY 0.0%
2015 - CNY 0.0%
2014 - CNY 0.0%
2013 - CNY 0.0%
2012 - CNY 0.0%
2011 - CNY -100.0%
2010 419.9 Million CNY 23.35%
2009 340.42 Million CNY -8.25%
2008 371.02 Million CNY -45.64%
2007 682.48 Million CNY -33.09%
2006 1.01 Billion CNY -19.92%
2005 1.27 Billion CNY 69.72%
2004 750.45 Million CNY 83.04%
2003 410 Million CNY 1.23%
2002 405 Million CNY -0.61%
2001 407.48 Million CNY 131.61%
2000 175.93 Million CNY 24.56%
1999 141.24 Million CNY 165.29%
1998 53.24 Million CNY 148.9%
1997 21.39 Million CNY -18.82%
1996 26.35 Million CNY 229.38%
1995 8 Million CNY 166.67%
1994 3 Million CNY 0.0%

Peer Total Debt Comparison of Ginwa Enterprise (Group) Inc.

Name Total Debt Total Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 1.58 Billion CNY 99.319%
Yabao Pharmaceutical Group Co., Ltd 209 Million CNY 94.844%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 15.79 Billion CNY 99.932%
Harbin Pharmaceutical Group Co., Ltd. 3.55 Billion CNY 99.697%
Tasly Pharmaceutical Group Co., Ltd 2.95 Billion CNY 99.636%
Zhejiang Medicine Co., Ltd. 801.44 Million CNY 98.655%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 839.84 Million CNY 98.717%
Lionco Pharmaceutical Group Co.,Ltd. 565.61 Million CNY 98.095%
Humanwell Healthcare (Group) Co.,Ltd. 9.94 Billion CNY 99.892%
Joincare Pharmaceutical Group Industry Co.,Ltd. 7.4 Billion CNY 99.854%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 175.68 Million CNY 93.866%
China Animal Husbandry Industry Co., Ltd. 1.45 Billion CNY 99.26%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 9.91 Million CNY -8.738%
Zhejiang Huahai Pharmaceutical Co., Ltd. 7.45 Billion CNY 99.855%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.08 Billion CNY 99.005%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.3 Billion CNY 99.173%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 727.9 Million CNY 98.52%
Chongqing Taiji Industry(Group) Co.,Ltd 4.86 Billion CNY 99.778%
HPGC Renmintongtai Pharmaceutical Corporation 2.33 Billion CNY 99.538%
Nanjing Well Pharmaceutical Group Co.,Ltd. 486.95 Million CNY 97.787%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 995.24 Million CNY 98.917%
Henan Lingrui Pharmaceutical Co., Ltd. 149.26 Million CNY 92.781%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.2 Billion CNY 99.105%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.07 Billion CNY 99.001%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 48.13 Million CNY 77.613%
Zhongzhu Healthcare Holding Co.,Ltd 23.94 Million CNY 54.991%
Beijing Tongrentang Co., Ltd 3.42 Billion CNY 99.686%
KPC Pharmaceuticals, Inc. 1.17 Billion CNY 99.08%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 17.28 Million CNY 37.645%
North China Pharmaceutical Company Ltd. 11.72 Billion CNY 99.908%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 462.87 Million CNY 97.672%
Tibet Weixinkang Medicine Co., Ltd. 7.68 Million CNY -40.274%
China National Medicines Corporation Ltd. 3.15 Billion CNY 99.659%
Zhejiang Hisun Pharmaceutical Co., Ltd. 5.69 Billion CNY 99.811%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.15 Billion CNY 99.658%
ChengDu ShengNuo Biotec Co.,Ltd. 267.22 Million CNY 95.967%
Dali Pharmaceuticalco.,Ltd 23.66 Million CNY 54.459%
Changchun BCHT Biotechnology Co. 20.47 Million CNY 47.362%
Zhejiang Shengda Bio-Pharm Co., Ltd. 238.44 Million CNY 95.481%
Shanghai Jiaoda Onlly Co.,Ltd 208.92 Million CNY 94.842%
Jiang Zhong Pharmaceutical Co.,Ltd 56.62 Million CNY 80.969%
Mayinglong Pharmaceutical Group Co., LTD. 380.42 Million CNY 97.167%
Cisen Pharmaceutical Co., Ltd. 170.67 Million CNY 93.686%
Hunan Warrant Pharmaceutical Co.,Ltd 24.18 Million CNY 55.437%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 35.72 Billion CNY 99.97%
Jianmin Pharmaceutical Group Co.,Ltd. 501.17 Million CNY 97.85%
Hunan Fangsheng Pharmaceutical Co., Ltd. 679.7 Million CNY 98.415%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.78 Billion CNY 99.396%
Guobang Pharma Ltd. 963.26 Million CNY 98.881%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 659.05 Million CNY 98.365%
Kangmei Pharmaceutical Co., Ltd. 255.01 Million CNY 95.774%
Shandong Buchang Pharmaceuticals Co., Ltd. 3.4 Billion CNY 99.684%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.19 Billion CNY 99.662%
Henan Taloph Pharmaceutical Stock Co.,Ltd 819.3 Million CNY 98.685%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 116.7 Million CNY 90.766%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.62 Billion CNY 99.59%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 446.65 Million CNY 97.587%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.75 Billion CNY 99.384%
Shanghai Yizhong Pharmaceutical Co., Ltd. 44.02 Million CNY 75.525%
Tibet Rhodiola Pharmaceutical Holding Co. 501.52 Million CNY 97.851%
Sichuan Huiyu Pharmaceutical Co., Ltd. 435.5 Million CNY 97.526%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 443.84 Million CNY 97.572%
CanSino Biologics Inc. 2.71 Billion CNY 99.603%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 705.78 Million CNY 98.473%
Shandong Lukang Pharmaceutical Co.,Ltd. 3.43 Billion CNY 99.686%